Qi-Xiang Li

Xiaoxi Xu¹, 

Limei Shang¹, 

Philip Wang², 

Jun Zhou², 

Xuesong Ouyang², 

Meiling Zheng¹, 

Binchen Mao², 

Likun Zhang², 

Bonnie Chen¹, 

Jingjing Wang², 

Jing Chen³, 

Wubin Qian², 

Sheng Guo², 

Yujun Huang², 

Qi-Xiang Li³ 

¹, Crown Bioscience Inc., Changping District, Beijing, China, 

², Crown Bioscience Inc., Taicang, Jiangsu, China, 

³, Crown Bioscience Inc., San Diego, CA, USA 

Marrit Putker^*,1, 

Rosemary Millen^*,2, 

René Overmeer^*,3, 

Else Driehuis^2,4, 

Maurice M. J. M. Zandvliet⁵, 

Hans Clevers², 

Sylvia F. Boj³, 

Qi-Xiang Li⁶ 

¹, Crown Bioscience Netherlands B.V., 

²Oncode Institute, Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center Utrecht, 

³, Hubrecht Organoid Technology (HUB), 

⁴Pathology dept, University Medical Center Utrecht, 

⁵Department of Clinical Sciences - Companion Animals, Faculty of Veterinary Medicine, Utrecht University, 

⁶, Crown Bioscience Inc.